Profit inroads for API

Australian Pharmaceutical Industries has reported net profit of $12.9 million for the first six months of its fiscal year, down 29.8 per cent on the previous corresponding period. But the previous result was boosted by $14.5 million in insurance proceeds. Underlying net profit, which excludes one-off items, rose 6.8 per cent. Sales were flat at $1.6 billion.

Australian Pharmaceutical Industries has reported net profit of $12.9 million for the first six months of its fiscal year, down 29.8 per cent on the previous corresponding period. But the previous result was boosted by $14.5 million in insurance proceeds. Underlying net profit, which excludes one-off items, rose 6.8 per cent. Sales were flat at $1.6 billion.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Join the Conversation...

There are comments posted so far.

If you'd like to join this conversation, please login or sign up here

Related Articles